PULMONX CORPORATION (LUNG) Free cash flow 2018–2025
PULMONX CORPORATION (LUNG) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$32.8MFY2025 · since FY2018: -$18.7M → -$32.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$32.8M | +0.5% |
| FY2024 | -$33.0M | +14.1% |
| FY2023 | -$38.4M | +17.2% |
| FY2022 | -$46.4M | -3.0% |
| FY2021 | -$45.1M | -42.8% |
| FY2020 | -$31.5M | -46.8% |
| FY2019 | -$21.5M | -14.8% |
| FY2018 | -$18.7M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice